vs
ABVC BIOPHARMA, INC.（ABVC）与Iveda Solutions, Inc.（IVDA）财务数据对比。点击上方公司名可切换其他公司
ABVC BIOPHARMA, INC.的季度营收约是Iveda Solutions, Inc.的1.3倍（$796.0K vs $626.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -258.6%，领先2.0%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs -64.1%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs 34.4%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
Iveda Solutions是一家专注于云边协同AI视频监控、物联网智能感知及智慧城市综合解决方案的科技企业，服务覆盖北美与亚太地区的公共部门、商业企业及教育机构，核心业务涵盖公共安全、智慧园区管理等领域。
ABVC vs IVDA — 直观对比
营收规模更大
ABVC
是对方的1.3倍
$626.0K
营收增速更快
ABVC
高出168.5%
-64.1%
净利率更高
ABVC
高出2.0%
-258.6%
两年增速更快
ABVC
近两年复合增速
34.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $626.0K |
| 净利润 | $-2.0M | $-1.6M |
| 毛利率 | 100.0% | 3.6% |
| 营业利润率 | -246.8% | -262.7% |
| 净利率 | -256.6% | -258.6% |
| 营收同比 | 104.5% | -64.1% |
| 净利润同比 | -417.4% | -7.1% |
| 每股收益（稀释后） | $-0.09 | $-0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCIVDA
| Q4 25 | — | $626.0K | ||
| Q3 25 | $796.0K | $1.7M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | $2.0K | $1.7M | ||
| Q3 24 | $389.3K | $2.4M | ||
| Q2 24 | $117.1K | $1.5M | ||
| Q1 24 | $1.2K | $346.8K |
净利润ABVCIVDA
| Q4 25 | — | $-1.6M | ||
| Q3 25 | $-2.0M | $-221.3K | ||
| Q2 25 | — | $-564.2K | ||
| Q1 25 | — | $-793.7K | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-394.8K | $-581.4K | ||
| Q2 24 | $-942.3K | $-599.0K | ||
| Q1 24 | $-2.8M | $-1.3M |
毛利率ABVCIVDA
| Q4 25 | — | 3.6% | ||
| Q3 25 | 100.0% | 31.3% | ||
| Q2 25 | — | 29.1% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | 100.0% | 11.9% | ||
| Q3 24 | 99.9% | 17.1% | ||
| Q2 24 | 99.8% | 32.7% | ||
| Q1 24 | 77.0% | 52.5% |
营业利润率ABVCIVDA
| Q4 25 | — | -262.7% | ||
| Q3 25 | -246.8% | -13.0% | ||
| Q2 25 | — | -34.8% | ||
| Q1 25 | — | -56.7% | ||
| Q4 24 | — | -87.3% | ||
| Q3 24 | -77.7% | -25.4% | ||
| Q2 24 | -734.2% | -39.7% | ||
| Q1 24 | -235539.8% | -384.1% |
净利率ABVCIVDA
| Q4 25 | — | -258.6% | ||
| Q3 25 | -256.6% | -13.4% | ||
| Q2 25 | — | -36.9% | ||
| Q1 25 | — | -53.8% | ||
| Q4 24 | — | -86.7% | ||
| Q3 24 | -101.4% | -24.2% | ||
| Q2 24 | -804.4% | -39.0% | ||
| Q1 24 | -235203.2% | -371.9% |
每股收益（稀释后）ABVCIVDA
| Q4 25 | — | $-0.33 | ||
| Q3 25 | $-0.09 | $-0.07 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | — | $-0.60 | ||
| Q3 24 | $-0.03 | $-0.27 | ||
| Q2 24 | $-0.08 | $-0.30 | ||
| Q1 24 | $-0.29 | $-0.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $5.2M |
| 总债务越低越好 | — | $393.4K |
| 股东权益账面价值 | $12.1M | $4.8M |
| 总资产 | $21.2M | $6.4M |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ABVCIVDA
| Q4 25 | — | $5.2M | ||
| Q3 25 | $257.2K | $3.3M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | $313.1K | $2.6M | ||
| Q3 24 | $208.2K | $3.6M | ||
| Q2 24 | $200.0K | $2.9M | ||
| Q1 24 | $106.4K | $3.9M |
总债务ABVCIVDA
| Q4 25 | — | $393.4K | ||
| Q3 25 | — | $306.4K | ||
| Q2 25 | — | $365.3K | ||
| Q1 25 | — | $340.8K | ||
| Q4 24 | — | $376.2K | ||
| Q3 24 | — | $545.9K | ||
| Q2 24 | — | $564.0K | ||
| Q1 24 | — | $480.0K |
股东权益ABVCIVDA
| Q4 25 | — | $4.8M | ||
| Q3 25 | $12.1M | $3.8M | ||
| Q2 25 | — | $1.5M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $1.2M | $2.5M | ||
| Q3 24 | $1.6M | $4.1M | ||
| Q2 24 | $1.8M | $2.8M | ||
| Q1 24 | $1.7M | $3.3M |
总资产ABVCIVDA
| Q4 25 | — | $6.4M | ||
| Q3 25 | $21.2M | $5.8M | ||
| Q2 25 | — | $4.4M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | $7.5M | $5.2M | ||
| Q3 24 | $7.8M | $9.1M | ||
| Q2 24 | $8.0M | $6.8M | ||
| Q1 24 | $8.0M | $6.6M |
负债/权益比ABVCIVDA
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $-252.4K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABVCIVDA
| Q4 25 | — | $-252.4K | ||
| Q3 25 | $-964.7K | $-317.0K | ||
| Q2 25 | — | $-1.3M | ||
| Q1 25 | — | $-126.0K | ||
| Q4 24 | $-1.8M | $-889.8K | ||
| Q3 24 | $60.2K | $-1.2M | ||
| Q2 24 | $-211.4K | $-999.7K | ||
| Q1 24 | $-955.8K | $-1.3M |
自由现金流ABVCIVDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-889.8K | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | — | $-1.1M | ||
| Q1 24 | — | $-1.5M |
自由现金流率ABVCIVDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -51.1% | ||
| Q3 24 | — | -64.1% | ||
| Q2 24 | — | -72.6% | ||
| Q1 24 | — | -427.3% |
资本支出强度ABVCIVDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 12.5% | ||
| Q2 24 | — | 7.5% | ||
| Q1 24 | — | 54.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
